Home » Topics » Regulatory

Regulatory
RSS

Tablet form of Rapamune receives FDA approval

Aug. 30, 2000

New findings on an old drug: metformin

Aug. 3, 2000

Clinical trial results disappointing for Provigil as treatment for adult ADHD

Aug. 2, 2000

Vaniqa approved by FDA for women with unwanted facial hair

Aug. 2, 2000

Celecoxib in familial adenomatous polyposis

Aug. 1, 2000

Cimetidine as treatment for viral warts in children and adults

Aug. 1, 2000

Anticancer combinations with synergistic activity

July 31, 2000

Methods of treating CFS with 5-HT3 antagonists described by Novartis

July 31, 2000

Combined AT1 antagonist and immunosuppressant for GvHD complications

July 31, 2000

Tetracyclines as a valuable and relatively safe therapy for corneal ulceration

July 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...